Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.OQ)

AUTL.OQ on NASDAQ Stock Exchange Global Select Market

33.45USD
7:41pm GMT
Change (% chg)

$-0.88 (-2.56%)
Prev Close
$34.33
Open
$35.43
Day's High
$35.43
Day's Low
$33.19
Volume
9,934
Avg. Vol
9,836
52-wk High
$53.14
52-wk Low
$19.33

Chart for

About

Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product candidates target hematological cancers. Its products candidates include AUTO2,... (more)

Overall

No Ratios Available.

Financials

  AUTL.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -- -- --
ROI: -- 9.01 14.96
ROE: -- 10.15 16.52

Earnings vs. Estimates